Removing one additional source of strain may have a greater impact.
In the long effort to understand how the brain ages under pressure, a new finding offers a quiet but meaningful signal: among adults living with epilepsy, those who address their hearing loss with hearing aids appear to face a 23% lower risk of developing dementia. Presented at the European Academy of Neurology Congress in 2026 by researchers from University Hospital Zurich and the University of Liverpool, the discovery is notable not only for what it found, but for where it found it — a benefit invisible in the general population and in six other high-risk groups, yet consistent and measurable in epilepsy alone. It suggests that when the brain is already laboring under one burden, relieving even a secondary strain may matter more than we imagined.
- Dementia risk in epilepsy patients who used hearing aids dropped by 23% — translating to one fewer case for every 37 people treated over five years.
- The signal appeared nowhere else: stroke, diabetes, heart failure, and five other high-risk groups showed no meaningful benefit, making epilepsy's response both surprising and scientifically compelling.
- Researchers believe the key lies in cognitive reserve — epilepsy depletes the brain's buffer against decline, so removing the added strain of untreated hearing loss produces a measurable effect that simply doesn't register in healthier brains.
- Biological plausibility strengthens the case: temporal lobe epilepsy damages hearing-related brain regions, and some anti-seizure medications worsen hearing, creating a convergence of vulnerabilities that hearing aids may help offset.
- Because epilepsy patients already see neurologists regularly, integrating routine hearing assessments into their care is a low-burden, low-risk step that clinicians could take now, even before prospective studies confirm causation.
Researchers analyzing electronic health records from more than 250 million patients have uncovered an unexpected pattern: adults with both epilepsy and hearing loss who wear hearing aids appear to have a 23% lower risk of developing dementia than those who do not. The finding, presented at the European Academy of Neurology Congress in 2026 by scientists from University Hospital Zurich and the University of Liverpool, emerged from a study designed to test whether correcting hearing loss might protect against cognitive decline in people already at elevated risk.
Hearing loss is widely recognized as the single largest modifiable risk factor for dementia, yet whether hearing aids actually reduce that risk — especially in people whose brains are already under strain — has remained uncertain. The researchers examined outcomes across seven high-risk groups, including people with stroke, diabetes, heart failure, and migraine. In every group but one, hearing aid use showed no meaningful association with dementia risk. Only in epilepsy did a consistent signal emerge.
Lead author Dr. Carolina Ferreira-Atuesta said the specificity surprised the team. The researchers believe the explanation lies in cognitive reserve — the brain's capacity to absorb damage and keep functioning. Most people with hearing loss retain enough reserve that correcting it produces little measurable effect. Epilepsy is different: the condition itself depletes that reserve, meaning the brain is already working harder to maintain normal function. Relieving the additional burden of untreated hearing loss, in that context, becomes measurable.
The biology supports this. Temporal lobe epilepsy affects regions involved in hearing, and some anti-seizure medications can worsen hearing as a side effect. These converging vulnerabilities may explain why the benefit appears here and nowhere else. Practically, the implications are immediate: epilepsy patients already see neurologists regularly, making hearing assessments easy to integrate into routine care. Hearing aids are established, reversible, and low-risk — and beyond dementia prevention, they improve communication, mood, and social connection. The study is observational and cannot yet prove causation, but its consistency and biological plausibility make a compelling case for action.
A team of researchers studying electronic health records across a network of more than 250 million patients has found something unexpected: adults living with both epilepsy and hearing loss who wear hearing aids appear to have a 23% lower risk of developing dementia than those who do not. The finding, presented at the European Academy of Neurology Congress in 2026, emerged from work by scientists at University Hospital Zurich and the University of Liverpool, who set out to test whether correcting hearing loss might offer protection against cognitive decline in people already facing elevated dementia risk.
Hearing loss has long been recognized as the single largest modifiable risk factor for dementia—a fact that has prompted public health campaigns and clinical guidelines urging people to address it. Yet whether hearing aids actually reduce dementia risk has remained an open question, particularly in people whose brains are already under strain from other conditions. The researchers decided to investigate whether the benefit might be especially pronounced in populations dealing with neurological, metabolic, or cardiovascular disease. They pulled data on adults with hearing loss, comparing those who used hearing aids with carefully matched peers who did not, then examined outcomes across several groups: people with epilepsy, stroke, type 2 diabetes, chronic kidney disease, heart failure, migraine, and osteoarthritis.
The results were striking in their specificity. Among the general population of people with hearing loss, hearing aid use showed no meaningful association with dementia risk. The same held true for people with stroke, migraine, diabetes, kidney disease, heart failure, or arthritis. But in the epilepsy group—and only in that group—the pattern reversed. Those using hearing aids had a 23% lower dementia risk, which translated to an absolute reduction of 2.7 percentage points over five years. In practical terms, that meant one fewer case of dementia for every 37 people who wore hearing aids.
Dr. Carolina Ferreira-Atuesta, the study's lead author, said the specificity of the finding surprised the team. They had expected to see modest benefits scattered across several high-risk groups. Instead, most showed nothing, while epilepsy showed a consistent signal across every analysis they ran. That consistency, she noted, lent credibility to the result. The researchers believe the explanation lies in how the brain manages cognitive load. Most people with hearing loss have enough cognitive reserve—the brain's capacity to keep functioning despite age-related wear or disease damage—to handle the extra mental effort that hearing impairment demands. Correcting that impairment may therefore have little effect on dementia risk. Epilepsy is different. The condition itself often depletes cognitive reserve, meaning the brain is already working harder just to maintain normal function. Remove one additional source of strain, like untreated hearing loss, and the benefit becomes measurable.
There are biological reasons this makes sense. Epilepsy is associated with accelerated cognitive decline. Temporal lobe epilepsy, a common form, affects brain regions involved in hearing. Some anti-seizure medications can worsen hearing as a side effect. All of these factors converge in ways that might make correcting hearing loss particularly valuable for people with epilepsy. The findings have immediate practical implications. People with epilepsy are already in regular contact with neurologists and other specialists. Hearing assessments could be woven into routine care without adding much burden. Hearing loss is straightforward to detect, and hearing aids are established, reversible, and carry minimal risk.
Ferreira-Atuesta emphasized that the case for action extends beyond dementia prevention. For people with epilepsy and hearing loss, treating the hearing loss improves communication, mood, and social connection—benefits that are well documented and real. The study was observational, meaning it cannot yet prove that hearing aids directly cause the dementia reduction. The researchers acknowledge that further prospective studies will be needed to confirm causation. But the findings are biologically plausible and consistent enough to warrant attention from clinicians and patients alike. For a vulnerable population facing a straightforward problem with a simple solution, that may be reason enough to act.
Citações Notáveis
What surprised us most was how specific the finding was to epilepsy. We expected to see a small benefit across several of the higher-risk groups we studied. Instead, most showed no significant association, while the association in epilepsy was observed consistently across all of our analyses.— Dr. Carolina Ferreira-Atuesta, lead researcher
Hearing loss is one of the few dementia risk factors we can actually do something about. It's easy to detect, and hearing aids are established, reversible and low-risk.— Dr. Carolina Ferreira-Atuesta
A Conversa do Hearth Outra perspectiva sobre a história
Why did epilepsy stand out when other serious conditions didn't?
The researchers think it comes down to cognitive reserve—how much mental capacity the brain has left over. Most people with hearing loss have enough reserve to absorb the strain. But epilepsy already depletes that reserve, so removing one source of stress actually matters.
So hearing aids are helping the brain work less hard?
Exactly. When your brain is already taxed by seizures and the cognitive effects of epilepsy, adding untreated hearing loss is one burden too many. Correcting it frees up resources.
Does this mean hearing aids prevent dementia in epilepsy, or just delay it?
That's the honest answer we don't have yet. This is observational data—it shows an association, not causation. You'd need a randomized trial to prove hearing aids actually prevent dementia. But the consistency of the finding across their analyses is encouraging.
What about the people in the study who didn't use hearing aids? Were they choosing not to, or were they not offered them?
The study doesn't tell us that. It's comparing people who used them with matched controls who didn't. There could be many reasons someone doesn't wear hearing aids—cost, stigma, not knowing they need them. That's part of why the researchers are calling for routine screening in epilepsy clinics.
If this holds up, what changes in practice?
Neurologists could add hearing assessments to standard epilepsy care. It's low-cost, low-risk, and the potential upside—even if it's just better communication and mood—makes it worth doing. For dementia prevention, you'd want to wait for more evidence.
Why hasn't anyone noticed this before?
Probably because epilepsy and hearing loss together are relatively uncommon. You need a huge dataset to spot the signal. That's why this analysis of 250 million patient records matters—it had the power to see something smaller studies would miss.